Vincent Mark D. 4/A
4/A · Aptose Biosciences Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4/AAmended
Vincent Mark D.
Director
Transactions
- Award
Director Option Grant
2020-03-11+50,000→ 50,000 totalExercise: $7.13From: 2021-03-11Exp: 2030-03-10→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]Converted from Canadian exercise price of C$9.80 using an exchange rate of 1.3745.